A Randomised, Double-Blind, Placebo-Controlled, Cross-Over, Single-Centre Study to Investigate the Acute Lung Deflation Effects of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg Once Daily on Cardiac Biventricular Function and Arterial Stiffness in Adults with COPD

dc.contributor.author	STONE, IS	en_US
dc.contributor.author	Shabbir, S	en_US
dc.contributor.author	Follows, RM	en_US
dc.contributor.author	Midwinter, DA	en_US
dc.contributor.author	Collier, SD	en_US
dc.date.accessioned	2015-04-29T08:26:59Z
dc.date.issued	2013-06-24	en_US
dc.identifier.uri	http://qmro.qmul.ac.uk/xmlui/handle/123456789/7359
dc.publisher	GlaxoSmithKline	en_US
dc.title	A Randomised, Double-Blind, Placebo-Controlled, Cross-Over, Single-Centre Study to Investigate the Acute Lung Deflation Effects of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg Once Daily on Cardiac Biventricular Function and Arterial Stiffness in Adults with COPD	en_US
dc.type	Other
dc.identifier.doi	10.17636/01007359	en_US
pubs.confidential	false	en_US
pubs.issue	HZC116601	en_US
pubs.notes	No embargo	en_US
pubs.notes	Study protocol record for submission to The Lancet	en_US
pubs.publication-status	Published	en_US

Files in this item

Files	Size	Format	View
There are no files associated with this item.